Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) believes that its patented technology, DehydraTECH™ has the potential to transform nicotine use by offering a delivery method that may be an effective alternative to the traditional inhalation. An article discussing the company reads: “Although inhalation is an effective delivery mechanism – much more so than non-enhanced edible ingestion – it is dangerous. The toxins released during combustion are harmful and can potentially kill the user. Edible ingestion eliminates the toxins caused by lighting up. While inhalation is fast, traditionally, ingestion has not been. However, the use of DehydraTECH™ speeds things up to make edible absorption roughly as fast as inhalation, allowing for non-deadly yet effective forms of absorption. This revolutionary technology makes it possible to experience most of the positives of inhalation while eliminating the negatives and making lighting up a thing of the past.”
To view the full article, visit http://nnw.fm/UpJx7
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. develops and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the U.S. and Australia for utilization of its DehydraTECH™ delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits for orally administered bioactive molecules, including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
More from NetworkNewsBreaks
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]